About UsPipelineTechnologyPartneringInvestor RelationsCareers
 
   
 

Micromet develops novel antibody-based drugs for
              the treatment of cancer, inflammation and autoimmune diseases.

  
   
 
Upcoming Events

August 5, 2010:

Q2 2010 Earnings Conference Call

August 11, 2010:

Canaccord Genuity 30th Annual Growth Conference
Latest News
Aug 10, 2010
Micromet to Present at the Canaccord Genuity 30th Annual Growth Conference
 more
Aug 05, 2010
Micromet Reports Second Quarter 2010 Financial Results
 more
Stock Quote
Exchange: NASDAQ Global Market
Ticker Symbol: MITI
Last Trade: $ 6.42
Change: $ -0.19
Date: Sep , 7 2010
Time: 4:00PM
(20 min delay)
 
   
ContactDirectionsEmail Alert 
HomeImprintLegal Notices